MLN2238 - CAS# 1072833-77-2 Catalog No.:M6657-2 159(2):964-9

159(2):964-9

SR9011 was used at 5-10 µM concentration in vitro and in cellular assays

InChi: InChI=1S/C21H16F4N4O2/c1-10-19(20(31)28-17-6-12-9-26-29-16(12)8-15(17)22)14(7-18(30)27-10)11-2-4-13(5-3-11)21(23

Pankratov TA

is selective β-TrCP1 ligase inhibitor

MLN2238 - CAS# 1072833-77-2 Catalog No.:M6657-2 159(2):964-9MLN2238, CAS No. 1072833 77 2, is a potent proteasome inhibitor (PI) with potential antineoplastic activity. MNL2238 is also . the biologically active form of MLN9708. MLN2238 has an improved pharmacodynamic profile and antitumor activity compared with bortezomib in both OCI Ly10 and PHTX22L models. Although both MLN2238 and bortezomib prolonged overall survival, reduced splenomegaly, and attenuated IgG2a levels in the iMyc(C) Bcl X(L) GEM model, only